4th October 2026, Sunday

TechPharus

Latest Posts

HealthTech News

  • Health records from 68 adults link plant-based grocery support to lower blood pressure and weight
    on October 4, 2026 at 7:24 pm

    Providing people with nutritious foods can improve the management of chronic metabolic diseases such as type 2 diabetes and hypertension. However, most studies of “Food Is Medicine” programs have only looked at their short-term impacts—on the scale of weeks to months.

  • Diet analysis links higher pulse intake to lower heart disease and diabetes risk
    on October 4, 2026 at 7:00 pm

    New research from two William & Mary students has found that the risk of heart attack could be significantly lowered with one simple dietary change: increasing the intake of pulses. But what is a pulse? A food group with diverse options, pulses are edible seeds from plants in the legume family. Some examples include dry beans, chickpeas, lentils and dry peas.

  • How blood vessels distinguish between growth and inflammation
    on October 4, 2026 at 5:00 pm

    The angiopoietin-Tie signaling pathway has long been known to be essential for the maturation and maintenance of healthy blood vessels. It stabilizes the vessel wall and regulates vascular growth during development. At the same time, it plays an important role in inflammation, when blood vessels become activated and immune cells leave the bloodstream and enter the surrounding tissue. How the same signaling pathway can control such different biological functions has remained unclear.

  • New technology advances understanding of eye pressure and glaucoma
    on October 4, 2026 at 3:40 pm

    For millions of people at risk of glaucoma, healthy eye pressure can mean the difference between preserving vision and losing it. Yet despite decades of research, scientists still do not fully understand what regulates daily changes in eye pressure or how those fluctuations may contribute to glaucoma. A series of three studies led by Christopher Passaglia, a University of South Florida professor and associate chair in the Department of Medical Engineering, is helping fill in those gaps.

  • Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer
    on October 4, 2026 at 2:20 pm

    Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer. However, before NRG-HN009, there was limited randomized evidence to determine which regimen provided the best balance of cancer control and treatment-related side effects.